Actionable news
0
All posts from Actionable news
Actionable news in RGLS: Regulus Therapeutics Inc.,

Regulus Announces Timing for First Quarter 2016 Financial Results Webcast and Conference Call

LA JOLLA, Calif., April 26, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights for the quarter ended March 31, 2016 on Monday, May 2, 2016, after the U.S. financial markets close.

Regulus will host a conference call and webcast on Monday, May 2, 2106, at 5:00 pm Eastern Daylight Time to discuss its first quarter 2016 financial results and recent company highlights. A live webcast of the call will be available online at www.regulusrx.com. To access the call, please dial (877) 257-8599 (domestic) or (970) 315-0459 (international) and refer to conference ID 99852289. To access the telephone replay of the call, dial (855) 859-2056 (domestic) or (404) 537-3406 (international), passcode 99852289. The webcast and telephone replay will be archived on the company's website following the call.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkers [SM] biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is developing...


More